occupational asthma
DESCRIPTION
Occupational Asthma. By : ziba Loukzadeh , M.D Occupational Medicine department Yazd University of Medical Sciences. Asthma (Introduction). Respiratory diseases cause loss of 5-38 million days per year. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/1.jpg)
By : ziba Loukzadeh, M.DBy : ziba Loukzadeh, M.DOccupational Medicine departmentOccupational Medicine department
Yazd University of Medical SciencesYazd University of Medical Sciences
![Page 2: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/2.jpg)
Respiratory diseases cause loss of 5-38 million days per year.
Asthma is the most common occupational respiratory disease In under development countries.
5-10% of U.S member. 15-20% of asthma cause from work.
![Page 3: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/3.jpg)
1. Airway obstruction Reversible obstruction(+/- treatment)
2. Airway inflammation3. Airway hyper responsiveness
As a consequence of working environment Not to stimuli of the outside the work
Definition
![Page 4: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/4.jpg)
diagnosis of asthma and by establishing a relationship between asthma and the work
environment
diagnosis of asthma should only be made when both intermittent respiratory
symptoms and physiologic evidence of reversible or variable airways obstruction are present
![Page 5: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/5.jpg)
Relationship between asthma and workplace exposure may fit any of the following patterns:
1. symptoms occur only at work2. symptoms improve on weekends or vacations3. symptoms occur regularly after the work shift4. symptoms progressively increase over the
course of the work week5. symptoms improve after a change in the work
environment
![Page 6: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/6.jpg)
Work-related O-A
work induced O-A work aggravated O-A
sensitizer induced irritant induced
![Page 7: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/7.jpg)
High molecular weight◦ Animal derived◦ Plant derived◦ Enzymes
Irritant agents◦ Chlorine◦ Acetic acid◦ Isocyanides
Low molecular weight◦ Spray paint◦ Wood dust (western red
cedar)◦ Acid anhydride◦ biocides◦ Colophony-fluxes
![Page 8: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/8.jpg)
H.M.WIg-E dependentMast cell & macrophage
L.M.WIg-E dependent
Hapten (platinum, isocyanat)Unknown mechanism
![Page 9: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/9.jpg)
Air way inflammation paramount feature of asthma.
Air way inflammation cause:◦ Obstruction◦ Hypersensitivity
Air way response include:◦ Rapid(1-2h)◦ Late (4-8 h)◦ Dual (1-2 & 4-8 h)
![Page 10: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/10.jpg)
![Page 11: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/11.jpg)
Dose-response relationship Latency period (>1 month up to 2year) and
dependent to:◦ Dose◦ Duration◦ Susceptibility
Skin contact (isocyanate) such as respiratory contact is important.
Environmental agents (smoking, O3, diesel gases, air allergen.)
![Page 12: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/12.jpg)
1. Atopy : HMW such as detergent enzymes
2. Smoking: ◦ platinum worker is the highest risk factor
3. non-allergic bronchial hyper-responsiveness
4. Genetic: isocyanate, platinum,red cedar,TMA
5. Upper air way symptom (rhinitis & conjunctivitis)
![Page 13: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/13.jpg)
cough , wheezing, dyspnea Some of persons involved Latency (month to years) Onset (rapid, late, dual) History of atopy, rhinitis, conjunctivitis Environmental investigation
◦ Ventilation , protective devices◦ Proper usage
![Page 14: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/14.jpg)
1. Spirometry across work shift:↓10% of FEV1
2. Serial monitoring of MCT: 3time ↑Pc20
3. Serial monitoring of PEF
4. Immunological tests: specific IgE →HMW & platinum Skin test
5. Specific challenge test: gold standard
6. NO, sputum induced analysis (Eos)
![Page 15: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/15.jpg)
![Page 16: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/16.jpg)
![Page 17: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/17.jpg)
![Page 18: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/18.jpg)
![Page 19: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/19.jpg)
![Page 20: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/20.jpg)
1. Removal from further exposure to that agent
2. Medical treatment like non-occupational asthma
If exposure is occasionally → wear protective respirator & fallow up
![Page 21: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/21.jpg)
Majority of patient fail to recover after removal
Associated with:◦ Exposure duration◦ Exposure amount after clinical symptom◦ Severity of symptoms (by PFT , challenge tests)◦ Delayed diagnosis◦ Inhalational corticosteroids
Early recognition of S-OA & removal
![Page 22: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/22.jpg)
1. Engineering control1.Substitution 2.Change of procedure3.isolation
2. Ventilation 3. Protective devices4. Restriction of employment5. Free from smoke6. Environmental screening
![Page 23: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/23.jpg)
Sudden adult-onset asthma (RADS)◦ After acute, massive, single exposure
Not-so-sudden, adult-onset asthma◦ After repeated, moderate-level exposure
![Page 24: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/24.jpg)
Volatile diisocyanates (TDI) Chlorine spills Acid spills, e.g., acetic acid Hypochlorite fumes Chemical fires Welding fumes Spray paint Metam sodium
![Page 25: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/25.jpg)
Onset of symptom within 24h Persistence symptom for at least 12w Objective evidence of asthma:
◦ Hyper responsiveness◦ Response to bronchodilator
No previously asthma, COPD, …
RADS Criteria
![Page 26: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/26.jpg)
Single high level exposure to irritant
![Page 27: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/27.jpg)
Atopy → no
Smoking → no
![Page 28: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/28.jpg)
Criteria
No investigation can prove the association with workplace
![Page 29: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/29.jpg)
Proper environmental control
Proper education
Proper drug treatment
Protective devices for RADS
Avoid from smoking ,dust ,fume
Control further high level exposure
![Page 30: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/30.jpg)
Symptoms persist for a few months – several years
![Page 31: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/31.jpg)
1. Asthma symptoms develop during the time an irritant exposure is occurring
2. No delay between the end of exposure & asthma onset (less than 24h)
3. May be airflow obstruction4. Positive MCT5. Exposure is intermittent or continuous6. Exposure persists for a few days to a few wks
Exposure lasts longer than 16 wks before onset of asthma → Dx is highly suspect
7. Evaluate susceptibility factors (90% of individual) Atopy Asthma in remission
![Page 32: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/32.jpg)
Chemical sensitivity◦ 15-30% of general population◦ Asthmalike symptoms after smelling chemical odor
Perfume, pesticide, fresh paint, cigarette smoke, new carpet, automobile exhaust, marker pens
![Page 33: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/33.jpg)
Prior asthma and aggregated with work:1. Drugs (aspirin, beta blocker, tarterazin)2. Environment (O3, SO2, NO2)3. Infections (RSV, influenza, para flu, rhinovirus).4. Exercise (cold and dry ventilation)5. Psychological6. Non active smokers
![Page 34: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/34.jpg)
Cigarette smoke
Fumes from cleaning agents
Dusts Paint Cold air Exercise Any irritants
![Page 35: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/35.jpg)
Airway hyper responsiveness → low level irritant (O3, respiratory infection, smoking) → bronchoconstriction
If asthma is well treated & avoid allergens → able to work with low level irritant (unlike S-OA)
![Page 36: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/36.jpg)
1. Symptoms worsen at work & improve at home + exposure at work to irritants
2. Objective evidence of asthma
3. Objective evidence of worsening at work Change in symptoms Medication PEF
![Page 37: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/37.jpg)
Optimize the medical management of asthma
limiting exposure to non-occupational irritants Such as tobacco smoke
Reduced exposure to non-specific exacerbating triggers in the workplace
![Page 38: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/38.jpg)
Depending on the exacerbating triggers:
◦ Move to a different work area
◦ Changes in ventilation or process
◦ Asthma education
◦ Appropriate respirator for short-term exposures to respiratory irritants
◦ Work modification to avoid extreme cold /exercise
![Page 39: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/39.jpg)
Temporary aggravation of asthma at work if there have been unusually high exposures to irritants such as when the workplace is being repainted, or is under construction
Such exposures are not known to cause long-term worsening of asthma and clinically usually resolve within a few weeks after cessation
![Page 40: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/40.jpg)
Optimum non-occupational environmental control measure
Asthma education Pharmacologic control of underlying asthma
Pre-employment counseling:◦ Work in a relatively clean environment with
limited expected exposure to dusts, smoke, fumes, and sprays, with moderate workplace temperatures and exertional requirements
![Page 41: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/41.jpg)
Current health (during the last 4 weeks)
If you run or climb stairs fast do you ever:•Cough?•Wheeze?•Get tight in the chest?
Yes/noYes/noYes/no
Is you sleep ever broken by:•Wheeze?•Difficulty with breathing?
Yes/noYes/no
Do you ever wake up in the morning with:•wheeze?•Difficulty with breathing?
Yes/noYes/no
Do you ever wheeze:•If you are in a smoky room?•If you are in a very dusty place?
Yes/noYes/no
91% sensitivity & 96 % specificity
![Page 42: Occupational Asthma](https://reader035.vdocuments.mx/reader035/viewer/2022062217/56813e5c550346895da8595a/html5/thumbnails/42.jpg)
Step Symptom Night Symptom
Lungfunction
medication
STEP 1: Mild intermittent
Symptoms two times a week Asymptomatic and normal PEF between exacerbations
<two times a month
FEV1 or PEF >80 percent predicted PEF variability <20 percent
Exacerbations may occur, A course of systemic corticosteroids is recommended.
STEP 2: Mild persistent
Symptoms > two times a week but < one time a day Exacerbations may affect activity
> two times a month
FEV1 or PEF >80 percent predicted PEF variability 20 to 30 percent
Lo w-dose inhaled corticosteroids
STEP 3: Moderate persistent
Daily symptoms Exacerbations two times a week
> one time a week
FEV1 or PEF >60 but <80 percent predicted PEF variability >30 percent
Low-to-medium dose inhaled corticosteroids and long-acting inhaled beta 2-agonists.
STEP 4: Severe persistent
Continual symptoms Limited physical activity Frequent exacerbations
Frequent FEV1 or PEF 60 percent predicted PEF variability >30 percent
High-dose inhaled corticosteroids AND Long-acting inhaled beta 2-agonists